Director sold ~$345K of Corcept Therapeutics
Scheduled in advanceTraded May 27, 2026 · Filed May 30, 2026
Corcept Therapeutics's See Remarks sold $1.35M of Corcept Therapeutics shares. It was planned long ago, so it says very little.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$1,351,316
Shares × reported transaction price
27 days after results of Apr 30, 2026, 63 days before results of Jul 29, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Footnote references a pre-arranged trading plan (Rule 10b5-1)
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +4.1% | −2.5% | +6.7% |
| 30 days | +25.6% | −1.7% | +27.3% |
| 90 days | +60.9% | +1.1% | +59.8% |
Past results only. Not a forecast.
Director sold ~$345K of Corcept Therapeutics
Scheduled in advanceDirector sold ~$487K of Corcept Therapeutics
Scheduled in advanceA board member of Corcept Therapeutics sold $1.69M of Corcept Therapeutics shares. Nobody planned it ahead of time.